We are excited to announce that we are now offering an innovative test with outstanding accuracy for the diagnosis of testicular cancer. The M371-Test is a qPCR-based assay intended as an aid for primary diagnosis and follow-up monitoring of testicular germ cell tumors (TGCTs).
Testicular germ cell tumors are the most common cancer type in men aged 20-45 years with 25.000 new cases per year in Europe (Source: Globocan 2020). The current gold standard for diagnosis and monitoring, based on serological testing, ultrasound, and CT imaging is unspecific, radiation-intensive and leaves the patient often in doubt.
The M371-Test is a qPCR-based assay intended as an aid for primary diagnosis and follow-up monitoring of testicular germ cell tumors (TGCT). It measures the relative quantity of the tumor marker miR-371a-3p from a blood sample with outstanding diagnostic accuracy.
Key features and benefits